Partner With Us NRI

FDC Ltd share Price

Company details

6M Return 4.49%
1Y Return 22.04%
Mkt Cap.(Cr) 4,942.46
Volume 228,683
Div Yield 0.00%
OI Chg %
Volume 228,683

Open Free Trading Account Online with ICICIDIRECT

FDC Ltd.

Q3FY23 Quarterly Result Announced for FDC Ltd.

Pharmaceutical firm FDC announced Q3FY23 results:

  • Consolidated Q3FY23 and 9MFY23:
    • India Market:
      • The sale of branded formulations in India for Q3FY23 was Rs 318 crore, with a growth of 10.2% on YoY and -14.1% on QoQ.
      • Overall sales in the Indian market accounted for 78% of total consolidated sales for the quarter.
      • For 9MFY23 sales were at Rs 1,109 crore, growth of 8.1% over the same period last year.
      • As per secondary sales data by IQVIA for the quarter that ended Dec 31, 2022, the company delivered strong YoY growth of 17.5% compared to the Indian Pharmaceutical Market (IPM) growth of 10.0% YoY.
    • Export Formulations Market:
      • Formulation sales in the export market were Rs 72 crore in Q3FY23, up by 84.2% over YoY and up by 24.6% over QoQ, accounting for 17% of total consolidated sales.
      • For 9MFY23 sales were Rs 185 crore, up by 55.3% over the same period last year. The main contributor is the USA market, accounting for 47% of total export formulations sales.
    • Export API Market:
      • API sales in the export market were Rs 20 crore in Q3FY23, up by 37.4% over YoY and accounted for 5% of total consolidated sales. For the 9MFY23, sales were Rs 55 crore, up by 31% over the same period last year.



Result PDF

View Other Company Results


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax



Equity Capital: 1,956.79 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 6,453.77 33,147.37
LAST 3M 17,843.41 60,442.99
LAST 6M 65,045.76 45,150.76
LAST 12M 117,698.99 96,636.68

FDC Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • FDC Ltd. is an Indian company engaged in the business of pharmaceuticals. It initiated the concept of Oral Rehydration Salts (ORS) and is now a pioneer in the segment with its brand Electral. The company was founded in 1936, with its headquarters in Aurangabad, Maharashtra. During the June 2022 quarter, its total income was Rs 513.79 crore, up 46.49% from the previous March 2022 quarter. On 27 October 2022, FDC Ltd.’s market capitalisation stood at Rs 5,006 crore.

    The company is listed on the Bombay Stock Exchange with the code FDC and on the National Stock Exchange with the code 531599.

    FDC Ltd. manufactures and distributes a range of generics, formulations, and active pharmaceutical ingredients (API) at its manufacturing plants. It also produces functional foods and beverages. Pyrimon, Cotaryl, Zifi, Enerzal, Electral, Vitcofol, Zathrin, Zoxan, Zocon, Zefu, Mycoderm, and Zipod are some of the brands owned by the company.

    On 30 June 2022, FDC Ltd.’s shareholding pattern showed public holdings of 20.1%, domestic institutional investor holdings of 6.08%, foreign institutional investor holdings of 4.34%, and promoter holdings of 69.5%. Ms Meera Ramdas Chandavarkar is the leading promoter, with a 19.4% share.

    The company’s top management comprises Mr Ramdas A Chandavarkar, Mr Nandan M Chandavarkar, Mr Ashok A Chandavarkar, Dr Mahesh Bijlani, Mr Sanjay Jain, Mr Mohan A Chandavarkar, CA Uday Kumar Gurkar, Mr Ameya A Chandavarkar, Mr Melarkode Ganesan Parameswaran, Ms Nomita R Chandavarkar, CA Swati S Mayekar, Ms Varsharani Kate, and Ms Usha Athreya Chandrasekhar. The company’s auditors are B S R & Co. LLP. As of 30 June 2022, the company’s total number of outstanding shares was 16.59 crores.

    On 27 October 2022, the company’s share price was trending at Rs 301.95 on BSE and Rs 301.75 on NSE. The company’s highest share price in 52 weeks was Rs 345, and the lowest price was Rs 225. By investing in FDC Ltd.’s shares, investors earned a six-month return of 9.26% and a one-year return of -7.97%.

    As of September 2022, ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund had a 3.21% stake in FDC Ltd. The company’s other mutual fund holdings include Tata India Pharma & Healthcare Fund, ITI Pharma and Healthcare Fund, and ICICI Prudential ESG Fund, with 2.39%, 1.93%, and 1.12% stakes, respectively.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

B-8 MIDC Industrial Area, Waluj Dist, Aurangabad (Maharashtra), Maharashtra, 431136

Tel : 91-240-2554407/967/299
Email : investors:fdcindia.com
Website : http://www.fdcindia.com

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 531599
NSE Code : FDC
Book Closure Date (Month) : Sep
BSE Group : A
ISIN : INE258B01022

FAQ’s on FDC Ltd Shares

You can buy FDC Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy FDC Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 08, 2023 03:58 PM the closing price of FDC Ltd was ₹ 297.90.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jun 08, 2023 03:58 PM, the market cap of FDC Ltd stood at ₹ 4,942.46.

The latest PE ratio of FDC Ltd as of Jun 08, 2023 03:58 PM is 25.45

The latest PB ratio of FDC Ltd as of Jun 08, 2023 03:58 PM is 0.40

The 52-week high of FDC Ltd is ₹ 318.00 while the 52-week low is ₹ 225.00

Download Our App

market app
market app